After Pfizer launched yet another takeover bid for AstraZeneca (LSE: AZN) (NYSE: AZN.US) and the latter turned it down once more, Jill Ralph and Nate Weisshaar take a closer look at the UK-based pharmaceutical company in this investing video, and ask what Astra shareholders should be doing now…
https://youtu.be/uyHwiRVZ0Hk
Should you buy AstraZeneca Plc shares today?
Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.
That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.